DUAL ACTION ANTIBACTERIAL WIPES

DUAL ACTION ANTIBACTERIAL WIPES was reported 334 times

DUAL ACTION ANTIBACTERIAL WIPES is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PARALYTIC GAIT 1 0.3333
1 SYNOVIAL FLUID ANALYSIS 13 0.1494
2 CONJUNCTIVAL SCAR 11 0.0728
3 KERATOUVEITIS 2 0.0541
4 RED BLOOD CELL SEDIMENTATION RATE DECREASED 11 0.0421
5 CONJUNCTIVAL GRANULOMA 1 0.0345
6 SYNOVIAL DISORDER 13 0.0286
7 TENOSYNOVITIS STENOSANS 13 0.0233
8 CATARACT TRAUMATIC 1 0.0233
9 HEPATIC ENZYME DECREASED 10 0.0223
10 GASTROINTESTINAL TOXICITY 107 0.0222
11 WRONG PRODUCT PROCURED 1 0.0152
12 C-REACTIVE PROTEIN ABNORMAL 97 0.0151
13 PULMONARY TOXICITY 106 0.0150
14 TOXIC ANTERIOR SEGMENT SYNDROME 15 0.0137
15 VAGINAL FLATULENCE 4 0.0132
16 ALLERGY TO CHEMICALS 14 0.0112
17 PROSTHESIS USER 1 0.0111
18 CHEST EXPANSION DECREASED 1 0.0108
19 CHEMICAL EYE INJURY 1 0.0102
20 APPLICATION SITE NECROSIS 1 0.0097
21 BONE TRIMMING 1 0.0088
22 KERATIC PRECIPITATES 4 0.0084
23 OLIGODENDROGLIOMA 1 0.0083
24 SCLERITIS 13 0.0081
25 CORNEAL NEOVASCULARISATION 2 0.0081
26 NASAL FLARING 1 0.0074
27 CONJUNCTIVAL IRRITATION 1 0.0074
28 PRIMARY HYPERALDOSTERONISM 1 0.0064
29 EYE PARAESTHESIA 1 0.0064
30 APPLICATION SITE WOUND 1 0.0061
31 LARYNGEAL INJURY 1 0.0058
32 MICROSPORIDIA INFECTION 2 0.0057
33 GRANULOCYTOSIS 1 0.0051
34 JOINT INJURY 106 0.0050
35 HEPATOTOXICITY 108 0.0048
36 RHEUMATOID NODULE 13 0.0047
37 TENOSYNOVITIS 13 0.0047
38 PLEURITIC PAIN 13 0.0047
39 MEIBOMIAN GLAND DYSFUNCTION 2 0.0044
40 GRIP STRENGTH 1 0.0044
41 CREPITATIONS 13 0.0044
42 CUSHINGOID 14 0.0044
43 STATUS ASTHMATICUS 2 0.0042
44 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
45 ANTINUCLEAR ANTIBODY POSITIVE 13 0.0040
46 REACTION TO PRESERVATIVES 3 0.0037
47 ENTEROCOLITIS BACTERIAL 1 0.0036
48 DAIRY INTOLERANCE 1 0.0036
49 JOINT STIFFNESS 93 0.0035
50 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
51 CELLULITIS ORBITAL 2 0.0034
52 FACET JOINT SYNDROME 11 0.0034
53 BRONCHOSPASM PARADOXICAL 1 0.0033
54 CATARACT SUBCAPSULAR 2 0.0033
55 TACHYPHYLAXIS 1 0.0029
56 RADIAL NERVE PALSY 1 0.0028
57 SYNOVIAL CYST 13 0.0028
58 GLOBULINS INCREASED 1 0.0027
59 CHEMICAL BURN 3 0.0026
60 REACTION TO EXCIPIENT 6 0.0026
61 THERAPY NON-RESPONDER 113 0.0025
62 USE OF ACCESSORY RESPIRATORY MUSCLES 1 0.0024
63 ARTERIAL THROMBOSIS LIMB 1 0.0024
64 HAEMOGLOBIN INCREASED 11 0.0024
65 LUPUS VULGARIS 3 0.0024
66 FEMALE GENITAL TRACT FISTULA 4 0.0023
67 PEAK EXPIRATORY FLOW RATE DECREASED 1 0.0023
68 LACRIMATION DECREASED 1 0.0021
69 BONE DEBRIDEMENT 1 0.0021
70 MUSCULOSKELETAL PAIN 108 0.0021
71 INTRAOCULAR LENS IMPLANT 1 0.0020
72 JOINT EFFUSION 13 0.0019
73 ARTHROPATHY 98 0.0018
74 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
75 NEOPLASM MALIGNANT 108 0.0016
76 CHALAZION 1 0.0016
77 NODULAR REGENERATIVE HYPERPLASIA 1 0.0016
78 C-REACTIVE PROTEIN DECREASED 1 0.0015
79 RADICULOPATHY 4 0.0015
80 LYMPHOCELE 1 0.0015
81 DUODENAL ULCER PERFORATION 11 0.0015
82 RETINAL PIGMENT EPITHELIAL TEAR 1 0.0014
83 FOLLICULITIS 15 0.0014
84 PROCTITIS 4 0.0014
85 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 101 0.0014
86 DEFORMITY 13 0.0014
87 FLANK PAIN 13 0.0014
88 INFANTILE SPASMS 1 0.0014
89 STOMA SITE PAIN 2 0.0014
90 ATELECTASIS 13 0.0013
91 LYMPH NODE TUBERCULOSIS 1 0.0013
92 ASEPTIC NECROSIS BONE 1 0.0013
93 TREATMENT FAILURE 105 0.0013
94 MUSCULOSKELETAL STIFFNESS 111 0.0013
95 TENDERNESS 13 0.0012
96 BLEPHARITIS 5 0.0012
97 SKIN BACTERIAL INFECTION 1 0.0012
98 ABDOMINAL SYMPTOM 1 0.0012
99 CHEMICAL INJURY 1 0.0012
100 CONTRAINDICATED PRODUCT ADMINISTERED 37 0.0012
101 BURSITIS 14 0.0012
102 BLOOD ALBUMIN INCREASED 1 0.0011
103 STOMA SITE ERYTHEMA 2 0.0011
104 APPLICATION SITE DERMATITIS 1 0.0011
105 HELICOBACTER INFECTION 11 0.0011
106 HAND DEFORMITY 14 0.0011
107 CHRONIC SINUSITIS 4 0.0011
108 INTUSSUSCEPTION 1 0.0010
109 QUALITY OF LIFE DECREASED 14 0.0010
110 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
111 ALLERGIC REACTION TO EXCIPIENT 2 0.0010
112 NODULE 13 0.0010
113 DRUG INTOLERANCE 94 0.0010
114 JOINT RANGE OF MOTION DECREASED 13 0.0010
115 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
116 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 1 0.0009
117 PNEUMONIA STREPTOCOCCAL 1 0.0009
118 JOINT SWELLING 107 0.0009
119 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
120 DISLOCATION OF VERTEBRA 2 0.0009
121 OPTIC NERVE INJURY 1 0.0009
122 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
123 THERAPEUTIC PRODUCT EFFECT DECREASED 37 0.0008
124 MONOCYTE COUNT DECREASED 1 0.0008
125 ULCER 13 0.0008
126 HAEMATOCRIT ABNORMAL 1 0.0008
127 BLADDER DISCOMFORT 1 0.0008
128 OVARIAN CYST RUPTURED 1 0.0008
129 RETINAL DEGENERATION 1 0.0008
130 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
131 INFECTION 110 0.0008
132 TUMOUR PAIN 1 0.0008
133 CONJUNCTIVITIS 14 0.0008
134 RHINALGIA 2 0.0007
135 TOXIC EPIDERMAL NECROLYSIS 11 0.0007
136 MENINGITIS BACTERIAL 1 0.0007
137 PORPHYRIA ACUTE 1 0.0007
138 INFLAMMATION 36 0.0007
139 PHOTOPHOBIA 13 0.0007
140 FEELING JITTERY 13 0.0007
141 CONJUNCTIVITIS ALLERGIC 1 0.0007
142 KERATITIS 2 0.0007
143 SCIATICA 10 0.0006
144 SKIN ULCER 16 0.0006
145 OPTIC ATROPHY 1 0.0006
146 IMPAIRED WORK ABILITY 13 0.0006
147 MUSCLE INJURY 5 0.0006
148 GLIOBLASTOMA 1 0.0006
149 RASH MACULO-PAPULAR 13 0.0006
150 BLOOD AMYLASE INCREASED 1 0.0006
151 PRODUCT PREPARATION ERROR 12 0.0006
152 RETINITIS 1 0.0006
153 FIBROMYALGIA 14 0.0006
154 INFUSION SITE DISCHARGE 1 0.0006
155 PANCREATIC FAILURE 1 0.0006
156 BONE EROSION 2 0.0006
157 PURULENCE 1 0.0005
158 HYPERAEMIA 1 0.0005
159 MACULAR DEGENERATION 6 0.0005
160 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
161 GLOSSODYNIA 11 0.0005
162 OCULAR HYPERAEMIA 23 0.0005
163 RHEUMATOID ARTHRITIS 53 0.0005
164 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3 0.0005
165 CORNEAL DISORDER 1 0.0005
166 RED BLOOD CELL COUNT DECREASED 13 0.0005
167 CORNEAL OEDEMA 1 0.0004
168 EYELID DISORDER 1 0.0004
169 LICHEN PLANUS 1 0.0004
170 PRURITUS GENITAL 1 0.0004
171 BONE DENSITY DECREASED 13 0.0004
172 STILLBIRTH 2 0.0004
173 APPLICATION SITE BURN 2 0.0004
174 IMPAIRED HEALING 13 0.0004
175 VAGINAL DISCHARGE 4 0.0004
176 BLOOD CHLORIDE DECREASED 1 0.0004
177 ORAL CANDIDIASIS 5 0.0004
178 PAIN IN EXTREMITY 111 0.0004
179 CONDITION AGGRAVATED 114 0.0004
180 COMPRESSION FRACTURE 2 0.0004
181 ULCERATIVE KERATITIS 1 0.0004
182 C-REACTIVE PROTEIN INCREASED 13 0.0004
183 TYPE 2 DIABETES MELLITUS 12 0.0004
184 DRUG TOLERANCE DECREASED 1 0.0004
185 RETINAL VEIN OCCLUSION 1 0.0003
186 HYPERVENTILATION 2 0.0003
187 ABORTION 1 0.0003
188 PULMONARY PAIN 1 0.0003
189 DRY EYE 17 0.0003
190 LIVER DISORDER 15 0.0003
191 HYPERCAPNIA 1 0.0003
192 INTERSTITIAL LUNG DISEASE 16 0.0003
193 EYE IRRITATION 19 0.0003
194 EYE INJURY 1 0.0003
195 IRITIS 1 0.0003
196 EXOSTOSIS 3 0.0003
197 APPLICATION SITE IRRITATION 4 0.0003
198 INJECTION SITE HYPERSENSITIVITY 1 0.0003
199 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
200 BREAST CANCER STAGE III 2 0.0003
201 POSTURE ABNORMAL 1 0.0003
202 THROMBOSIS IN DEVICE 1 0.0003
203 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
204 PRODUCT LABEL ISSUE 2 0.0003
205 CONJUNCTIVAL HYPERAEMIA 1 0.0003
206 PARAESTHESIA ORAL 4 0.0003
207 ASTHMATIC CRISIS 1 0.0003
208 PERIPHERAL SWELLING 42 0.0003
209 BLINDNESS TRANSIENT 2 0.0003
210 FOOT DEFORMITY 3 0.0003
211 ARTHRALGIA 112 0.0003
212 EYE PAIN 15 0.0003
213 LUNG DISORDER 13 0.0003
214 DERMATITIS CONTACT 3 0.0003
215 OESOPHAGEAL DISORDER 1 0.0003
216 RASH PRURITIC 14 0.0003
217 WHEEZING 15 0.0003
218 MEDICATION ERROR 14 0.0003
219 PERIPHERAL VENOUS DISEASE 1 0.0002
220 PERIPHERAL ISCHAEMIA 1 0.0002
221 INFUSION RELATED REACTION 16 0.0002
222 ROAD TRAFFIC ACCIDENT 10 0.0002
223 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
224 PSEUDOMONAS INFECTION 2 0.0002
225 PAPILLOEDEMA 1 0.0002
226 RESPIRATORY DISTRESS 6 0.0002
227 ROSACEA 1 0.0002
228 SKIN ABRASION 1 0.0002
229 SARCOIDOSIS 1 0.0002
230 BRONCHOSPASM 3 0.0002
231 HYPERCHOLESTEROLAEMIA 2 0.0002
232 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
233 OVARIAN CYST 2 0.0002
234 SWELLING FACE 13 0.0002
235 PHLEBITIS 1 0.0002
236 SWELLING 18 0.0002
237 IRRITABLE BOWEL SYNDROME 4 0.0002
238 INJECTION SITE DISCHARGE 1 0.0002
239 FREQUENT BOWEL MOVEMENTS 5 0.0002
240 DEAFNESS UNILATERAL 1 0.0002
241 THROMBOSIS 14 0.0002
242 DRY MOUTH 14 0.0002
243 PRODUCT LABEL CONFUSION 1 0.0002
244 URINE ODOUR ABNORMAL 1 0.0002
245 HEARING IMPAIRED 1 0.0002
246 HEPATITIS CHOLESTATIC 1 0.0002
247 ARTHRITIS 13 0.0002
248 PEMPHIGUS 2 0.0002
249 HEPATIC CIRRHOSIS 3 0.0002
250 COLITIS ULCERATIVE 7 0.0002
251 MYDRIASIS 2 0.0002
252 GLAUCOMA 3 0.0002
253 HAEMOGLOBIN ABNORMAL 1 0.0002
254 POOR QUALITY DRUG ADMINISTERED 1 0.0002
255 APPLICATION SITE VESICLES 1 0.0002
256 ASPERGILLUS INFECTION 1 0.0002
257 PRODUCT FORMULATION ISSUE 1 0.0002
258 EAR INFECTION 4 0.0002
259 WRONG PRODUCT ADMINISTERED 1 0.0001
260 ULCER HAEMORRHAGE 1 0.0001
261 SINUSITIS 15 0.0001
262 PROCEDURAL PAIN 4 0.0001
263 RETINAL HAEMORRHAGE 1 0.0001
264 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
265 HYPOKINESIA 2 0.0001
266 MAJOR DEPRESSION 1 0.0001
267 HAEMOGLOBIN DECREASED 14 0.0001
268 FEELING DRUNK 1 0.0001
269 FOOD ALLERGY 1 0.0001
270 ATRIOVENTRICULAR BLOCK 1 0.0001
271 CONCUSSION 1 0.0001
272 VISUAL IMPAIRMENT 16 0.0001
273 APHTHOUS ULCER 1 0.0001
274 SLEEP DISORDER 9 0.0001
275 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
276 NASAL DISCOMFORT 1 0.0001
277 BLISTER 7 0.0001
278 RHINITIS 1 0.0001
279 PERICARDITIS 2 0.0001
280 INFUSION SITE ERYTHEMA 1 0.0001
281 MUSCULAR WEAKNESS 13 0.0001
282 GRIP STRENGTH DECREASED 1 0.0001
283 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
284 COLITIS 4 0.0001
285 LOWER LIMB FRACTURE 2 0.0001
286 ACUTE RESPIRATORY FAILURE 2 0.0001
287 PRESCRIBED OVERDOSE 2 0.0001
288 AUTOIMMUNE DISORDER 1 0.0001
289 LACRIMATION INCREASED 3 0.0001
290 STOMATITIS 6 0.0001
291 HYPOTHERMIA 1 0.0001
292 EYELID PTOSIS 1 0.0001
293 EYE DISCHARGE 1 0.0001
294 DRUG INEFFECTIVE 126 0.0001
295 WEIGHT FLUCTUATION 1 0.0001
296 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
297 JOINT DISLOCATION 1 0.0001
298 RECTAL HAEMORRHAGE 4 0.0001
299 STEVENS-JOHNSON SYNDROME 2 0.0001
300 EYE PRURITUS 3 0.0001
301 ERYTHEMA 18 0.0001
302 DELIRIUM 3 0.0001
303 COVID-19 PNEUMONIA 1 0.0001
304 ADRENAL INSUFFICIENCY 1 0.0001
305 BACK PAIN 19 0.0001
306 ABDOMINAL PAIN 19 0.0001
307 INJECTION SITE URTICARIA 2 0.0001
308 TOOTH EXTRACTION 1 0.0001
309 INJECTION SITE DISCOLOURATION 1 0.0001
310 BRAIN OEDEMA 1 0.0001
311 INFUSION SITE PAIN 1 0.0001
312 MYALGIA 13 0.0001
313 APPLICATION SITE ERYTHEMA 2 0.0001
314 HYPERSENSITIVITY 14 0.0001
315 MALIGNANT MELANOMA 1 0.0001
316 HYPOAESTHESIA 11 0.0001
317 PNEUMONITIS 2 0.0001
318 PERIPHERAL COLDNESS 1 0.0001
319 RESPIRATORY ARREST 2 0.0001
320 HAEMATOCHEZIA 4 0.0001
321 ORAL DISCOMFORT 1 0.0001
322 HUNGER 1 0.0001
323 DEVICE OCCLUSION 1 0.0001
324 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
325 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
326 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
327 HAEMORRHAGE INTRACRANIAL 1 0.0001
328 LIMB DISCOMFORT 2 0.0001
329 LUNG INFECTION 1 0.0001
330 BASAL CELL CARCINOMA 1 0.0001
331 DRUG-INDUCED LIVER INJURY 2 0.0001
332 OBESITY 1 0.0001
333 RASH ERYTHEMATOUS 3 0.0001
334 ABSCESS 1 0.0001
335 FEELING ABNORMAL 15 0.0001
336 NIGHT SWEATS 2 0.0001
337 RASH 27 0.0001
338 HYPERTENSION 13 0.0001
339 EYE DISORDER 2 0.0001
340 PYREXIA 21 0.0001
341 CARDIAC ARREST 5 0.0001
342 PHOTOSENSITIVITY REACTION 1 0.0001
343 VISUAL ACUITY REDUCED 2 0.0001
344 CYTOMEGALOVIRUS INFECTION 1 0.0001
345 COAGULOPATHY 1 0.0001
346 SKIN DISORDER 2 0.0001
347 GAIT INABILITY 2 0.0001
348 BLOOD UREA INCREASED 1 0.0001
349 CANDIDA INFECTION 1 0.0001
350 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
351 ANAEMIA 11 0.0001
352 HYPOXIA 2 0.0001
353 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
354 DRUG ERUPTION 1 0.0001
355 ISCHAEMIC STROKE 1 0.0001
356 CEREBRAL HAEMORRHAGE 2 0.0001
357 SYNOVITIS 1 0.0001
358 EYE SWELLING 2 0.0001
359 BLOOD SODIUM DECREASED 1 0.0001
360 NEUROPATHY PERIPHERAL 5 0.0001
361 PULMONARY FIBROSIS 1 0.0001
362 EAR PAIN 1 0.0001
363 DYSPEPSIA 5 0.0001
364 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
365 CATARACT 3 0.0001
366 WEIGHT DECREASED 14 0.0001
367 PRESCRIBED UNDERDOSE 1 0.0001
368 ILL-DEFINED DISORDER 3 0.0000
369 EXTRA DOSE ADMINISTERED 2 0.0000
370 OFF LABEL USE 43 0.0000
371 BODY TEMPERATURE INCREASED 1 0.0000
372 PAIN 30 0.0000
373 MALAISE 21 0.0000
374 DERMATITIS 1 0.0000
375 RENAL FAILURE ACUTE 2 0.0000
376 PRURITUS 18 0.0000
377 MELAENA 1 0.0000
378 GASTROINTESTINAL DISORDER 4 0.0000
379 PANCREATITIS ACUTE 1 0.0000
380 APPLICATION SITE PRURITUS 1 0.0000
381 SKIN DISCOLOURATION 2 0.0000
382 PERICARDIAL EFFUSION 1 0.0000
383 PNEUMONIA 14 0.0000
384 RESPIRATORY FAILURE 3 0.0000
385 LIVER INJURY 1 0.0000
386 PNEUMONIA ASPIRATION 1 0.0000
387 PRODUCT COMPLAINT 1 0.0000
388 HAEMATEMESIS 1 0.0000
389 INJECTION SITE SWELLING 3 0.0000
390 DYSPNOEA 22 0.0000
391 UNRESPONSIVE TO STIMULI 1 0.0000
392 HAEMATOMA 1 0.0000
393 INJECTION SITE BRUISING 3 0.0000
394 INJECTION SITE HAEMORRHAGE 3 0.0000
395 JAUNDICE 1 0.0000
396 CONFUSIONAL STATE 6 0.0000
397 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
398 DIVERTICULITIS 1 0.0000
399 SKIN EXFOLIATION 3 0.0000
400 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
401 HERPES ZOSTER 2 0.0000
402 SEIZURE 4 0.0000
403 ASCITES 1 0.0000
404 LABORATORY TEST ABNORMAL 1 0.0000
405 RESPIRATORY DISORDER 1 0.0000
406 DISCOMFORT 2 0.0000
407 FEELING HOT 2 0.0000
408 DRUG ADMINISTRATION ERROR 1 0.0000
409 ADVERSE EVENT 3 0.0000
410 NASOPHARYNGITIS 6 0.0000
411 HOSPITALISATION 5 0.0000
412 CHEST PAIN 6 0.0000
413 HEAD INJURY 1 0.0000
414 HYPOTHYROIDISM 1 0.0000
415 FATIGUE 24 0.0000
416 DEEP VEIN THROMBOSIS 2 0.0000
417 AMNESIA 2 0.0000
418 STAPHYLOCOCCAL INFECTION 1 0.0000
419 FEBRILE NEUTROPENIA 2 0.0000
420 DIZZINESS 15 0.0000
421 URINARY RETENTION 1 0.0000
422 INJECTION SITE PRURITUS 2 0.0000
423 TOXICITY TO VARIOUS AGENTS 5 0.0000
424 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
425 HAEMATURIA 1 0.0000
426 ILLNESS 3 0.0000
427 RASH MACULAR 1 0.0000
428 INJURY 2 0.0000
429 PLATELET COUNT DECREASED 3 0.0000
430 NAUSEA 22 0.0000
431 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
432 ACCIDENTAL OVERDOSE 1 0.0000
433 BRONCHITIS 2 0.0000
434 WEIGHT INCREASED 6 0.0000
435 EPISTAXIS 2 0.0000
436 HALLUCINATION 2 0.0000
437 DIARRHOEA 17 0.0000
438 PSORIATIC ARTHROPATHY 1 0.0000
439 BLINDNESS 1 0.0000
440 OSTEOPOROSIS 1 0.0000
441 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
442 OSTEOARTHRITIS 1 0.0000
443 HYPOACUSIS 1 0.0000
444 DEVICE LEAKAGE 1 0.0000
445 SEPTIC SHOCK 1 0.0000
446 MENTAL DISORDER 1 0.0000
447 CONSTIPATION 5 0.0000
448 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
449 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
450 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
451 THROAT IRRITATION 1 0.0000
452 VISION BLURRED 3 0.0000
453 MEMORY IMPAIRMENT 3 0.0000
454 MIGRAINE 2 0.0000
455 COLORECTAL CANCER 1 0.0000
456 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
457 CONTUSION 2 0.0000
458 LEUKOPENIA 1 0.0000
459 FLUSHING 2 0.0000
460 CHEST DISCOMFORT 2 0.0000
461 ABDOMINAL PAIN UPPER 4 0.0000
462 ECZEMA 1 0.0000
463 SPEECH DISORDER 1 0.0000
464 DERMATITIS ATOPIC 1 0.0000
465 PANCREATITIS 1 0.0000
466 BRADYCARDIA 1 0.0000
467 TREATMENT NONCOMPLIANCE 1 0.0000
468 URTICARIA 3 0.0000
469 PANCYTOPENIA 1 0.0000
470 ASTHMA 2 0.0000
471 HEADACHE 11 0.0000
472 LETHARGY 1 0.0000
473 PRODUCT SUBSTITUTION ISSUE 1 0.0000
474 DYSPHONIA 1 0.0000
475 BONE PAIN 1 0.0000
476 CHILLS 2 0.0000
477 NASAL CONGESTION 1 0.0000
478 IRRITABILITY 1 0.0000
479 THERAPEUTIC RESPONSE DECREASED 1 0.0000
480 EXPOSURE DURING PREGNANCY 1 0.0000
481 PRODUCT USE ISSUE 3 0.0000
482 LOSS OF CONSCIOUSNESS 2 0.0000
483 RHINORRHOEA 1 0.0000
484 BLOOD CREATININE INCREASED 1 0.0000
485 ALOPECIA 3 0.0000
486 INJECTION SITE REACTION 1 0.0000
487 COUGH 4 0.0000
488 BURNING SENSATION 1 0.0000
489 SKIN BURNING SENSATION 1 0.0000
490 MOBILITY DECREASED 1 0.0000
491 HOT FLUSH 1 0.0000
492 PARAESTHESIA 2 0.0000
493 CARDIAC FAILURE 1 0.0000
494 URINARY TRACT INFECTION 2 0.0000
495 PRODUCT STORAGE ERROR 1 0.0000
496 INSOMNIA 3 0.0000
497 TACHYCARDIA 1 0.0000
498 ADVERSE DRUG REACTION 1 0.0000
499 SUICIDAL IDEATION 1 0.0000
500 OROPHARYNGEAL PAIN 1 0.0000
501 BREAST CANCER 1 0.0000
502 CARDIAC DISORDER 1 0.0000
503 ASTHENIA 4 0.0000
504 VOMITING 5 0.0000
505 DYSPHAGIA 1 0.0000
506 PULMONARY EMBOLISM 1 0.0000
507 ABDOMINAL DISTENSION 1 0.0000
508 OVERDOSE 2 0.0000
509 INFLUENZA 1 0.0000
510 SEPSIS 1 0.0000
511 DECREASED APPETITE 2 0.0000
512 EMOTIONAL DISTRESS 1 0.0000
513 INJECTION SITE ERYTHEMA 1 0.0000
514 RENAL FAILURE 1 0.0000
515 DEHYDRATION 1 0.0000
516 DRY SKIN 1 0.0000
517 PRODUCT QUALITY ISSUE 1 0.0000
518 ANXIETY 2 0.0000
519 PRODUCT DOSE OMISSION ISSUE 2 0.0000
520 ACUTE KIDNEY INJURY 1 0.0000
521 INJECTION SITE PAIN 2 0.0000
522 DRUG INTERACTION 1 0.0000
523 TREMOR 1 0.0000
524 CEREBROVASCULAR ACCIDENT 1 0.0000
525 MYOCARDIAL INFARCTION 1 0.0000
526 COVID-19 1 0.0000
527 NO ADVERSE EVENT 1 0.0000
528 BLOOD GLUCOSE INCREASED 1 0.0000
529 GAIT DISTURBANCE 1 0.0000
530 HYPOTENSION 1 0.0000
531 DEPRESSION 1 0.0000
532 DEATH 3 0.0000
533 FALL 1 0.0000